Literature DB >> 22164744

Dealing with adverse reactions to snake antivenom.

I Gawarammana1, D Keyler.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22164744     DOI： 10.4038/cmj.v56i3.3594

Source DB:  PubMed          Journal:  Ceylon Med J        ISSN： 0009-0875


× No keyword cloud information.
  5 in total

Review 1.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

2.  Epidemiology of venomous and semi-venomous snakebites (Ophidia: Viperidae, Colubridae) in the Kashan city of the Isfahan province in Central Iran.

Authors:  Rouhullah Dehghani; Omid Mehrpour; Morteza Panjeh Shahi; Mehrdad Jazayeri; Parissa Karrari; Dan Keyler; Nasim Zamani
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

3.  Development of a Monoclonal scFv against Cytotoxin to Neutralize Cytolytic Activity Induced by Naja atra Venom on Myoblast C2C12 Cells.

Authors:  Chien-Chun Liu; Cho-Ju Wu; Tsai-Ying Chou; Geng-Wang Liaw; Yung-Chin Hsiao; Lichieh-Julie Chu; Chi-Hsin Lee; Po-Jung Wang; Cheng-Hsien Hsieh; Chun-Kuei Chen; Jau-Song Yu
Journal:  Toxins (Basel)       Date:  2022-07-04       Impact factor: 5.075

4.  Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation.

Authors:  Shelley F Stone; Geoffrey K Isbister; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Ariaranee Ariaratnam; Tamara E Jacoby-Alner; Claire L Cotterell; Simon G A Brown
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25

5.  Production, Characterisation and Testing of an Ovine Antitoxin against Ricin; Efficacy, Potency and Mechanisms of Action.

Authors:  Sarah J C Whitfield; Gareth D Griffiths; Dominic C Jenner; Robert J Gwyther; Fiona M Stahl; Lucy J Cork; Jane L Holley; A Christopher Green; Graeme C Clark
Journal:  Toxins (Basel)       Date:  2017-10-18       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.